233 related articles for article (PubMed ID: 36801811)
1. Transcriptomic profiling reveals distinct subsets of immune checkpoint inhibitor induced myositis.
Pinal-Fernandez I; Quintana A; Milisenda JC; Casal-Dominguez M; Muñoz-Braceras S; Derfoul A; Torres-Ruiz J; Pak K; Dell'Orso S; Naz F; Gutierrez-Cruz G; Milone M; Shelly S; Duque-Jaimez Y; Tobias-Baraja E; Matas-Garcia A; Garrabou G; Padrosa J; Ros J; Trallero-Araguás E; Walitt B; Christopher-Stine L; Lloyd TE; Zhao C; Swift S; Rajan A; Grau-Junyent JM; Selva-O'Callaghan A; Liewluck T; Mammen AL
Ann Rheum Dis; 2023 Jun; 82(6):829-836. PubMed ID: 36801811
[TBL] [Abstract][Full Text] [Related]
2. Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis.
Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Carrion-Ribas C; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Ann Rheum Dis; 2020 Sep; 79(9):1234-1242. PubMed ID: 32546599
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional derepression of CHD4/NuRD-regulated genes in the muscle of patients with dermatomyositis and anti-Mi2 autoantibodies.
Pinal-Fernandez I; Milisenda JC; Pak K; Muñoz-Braceras S; Casal-Dominguez M; Torres-Ruiz J; Dell'Orso S; Naz F; Gutierrez-Cruz G; Duque-Jaimez Y; Matas-Garcia A; Padrosa J; Garcia-Garcia FJ; Guitart-Mampel M; Garrabou G; Trallero-Araguás E; Walitt B; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Grau-Junyent JM; Selva-O'Callaghan A; Mammen AL
Ann Rheum Dis; 2023 Aug; 82(8):1091-1097. PubMed ID: 37130727
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic myopathies.
Mammen AL
Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
[TBL] [Abstract][Full Text] [Related]
5. Identification of distinctive interferon gene signatures in different types of myositis.
Pinal-Fernandez I; Casal-Dominguez M; Derfoul A; Pak K; Plotz P; Miller FW; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Paik J; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Neurology; 2019 Sep; 93(12):e1193-e1204. PubMed ID: 31434690
[TBL] [Abstract][Full Text] [Related]
6. The role of interferons type I, II and III in myositis: A review.
Bolko L; Jiang W; Tawara N; Landon-Cardinal O; Anquetil C; Benveniste O; Allenbach Y
Brain Pathol; 2021 May; 31(3):e12955. PubMed ID: 34043262
[TBL] [Abstract][Full Text] [Related]
7. Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy.
Muñoz-Braceras S; Pinal-Fernandez I; Casal-Dominguez M; Pak K; Milisenda JC; Lu S; Gadina M; Naz F; Gutierrez-Cruz G; Dell'Orso S; Torres-Ruiz J; Grau-Junyent JM; Selva-O'Callaghan A; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Cells; 2023 Sep; 12(17):. PubMed ID: 37681930
[TBL] [Abstract][Full Text] [Related]
8. Thigh muscle MRI in immune-mediated necrotising myopathy: extensive oedema, early muscle damage and role of anti-SRP autoantibodies as a marker of severity.
Pinal-Fernandez I; Casal-Dominguez M; Carrino JA; Lahouti AH; Basharat P; Albayda J; Paik JJ; Ahlawat S; Danoff SK; Lloyd TE; Mammen AL; Christopher-Stine L
Ann Rheum Dis; 2017 Apr; 76(4):681-687. PubMed ID: 27651398
[TBL] [Abstract][Full Text] [Related]
9. Muscular and extramuscular features of myositis patients with anti-U1-RNP autoantibodies.
Casal-Dominguez M; Pinal-Fernandez I; Corse AM; Paik J; Albayda J; Casciola-Rosen L; Johnson C; Danoff SK; Christopher-Stine L; Tiniakou E; Mammen AL
Neurology; 2019 Mar; 92(13):e1416-e1426. PubMed ID: 30824556
[TBL] [Abstract][Full Text] [Related]
10. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
Eymard B
Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy.
Das L; Blumbergs PC; Manavis J; Limaye VS
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation.
De Lorenzo R; Monno A; Sciorati C; Lorenzetti I; Cavalli S; Bonomi F; Previtali SC; Rovere-Querini P
Clin Exp Rheumatol; 2022 Feb; 40(2):237-246. PubMed ID: 34796850
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of autophagosome cargo protein p62 is common in idiopathic inflammatory myopathies.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau JM; Miller FW; Selva-O'Callaghan A; Christopher-Stine L; Stenzel W; Mammen AL; Corse AM
Clin Exp Rheumatol; 2021; 39(2):351-356. PubMed ID: 32896253
[TBL] [Abstract][Full Text] [Related]
15. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory muscle disease - An update.
Baig S; Paik JJ
Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101484. PubMed ID: 32046904
[TBL] [Abstract][Full Text] [Related]
17. Coexisting autoantibodies against transcription factor Sp4 are associated with decreased cancer risk in patients with dermatomyositis with anti-TIF1γ autoantibodies.
Hosono Y; Sie B; Pinal-Fernandez I; Pak K; Mecoli CA; Casal-Dominguez M; Warner BM; Kaplan MJ; Albayda J; Danoff S; Lloyd TE; Paik JJ; Tiniakou E; Aggarwal R; Oddis CV; Moghadam-Kia S; Carmona-Rivera C; Milisenda JC; Grau-Junyent JM; Selva-O'Callaghan A; Christopher-Stine L; Larman HB; Mammen AL
Ann Rheum Dis; 2023 Feb; 82(2):246-252. PubMed ID: 36008132
[TBL] [Abstract][Full Text] [Related]
18. Autophagy markers LC3 and p62 accumulate in immune-mediated necrotizing myopathy.
Girolamo F; Lia A; Annese T; Giannini M; Amati A; D'Abbicco D; Tampoia M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Trojano M
Muscle Nerve; 2019 Sep; 60(3):315-327. PubMed ID: 31172530
[TBL] [Abstract][Full Text] [Related]
19. Thigh MRI in antisynthetase syndrome, and comparisons with dermatomyositis and immune-mediated necrotizing myopathy.
Zhang W; Zheng Y; Wang Y; Xiong H; Que C; Zhang X; Zhu Y; Zhao Y; Yu M; Meng L; Lv H; Zhang W; Hao H; Xiao J; Yuan Y; Wang Z
Rheumatology (Oxford); 2022 Dec; 62(1):310-320. PubMed ID: 35512205
[TBL] [Abstract][Full Text] [Related]
20. Possible future avenues for myositis therapeutics: DM, IMNM and IBM.
Connolly CM; Plomp L; Paik JJ; Allenbach Y
Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101762. PubMed ID: 35778272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
